EBS Debt / Equity | EMERGENT BIOSOLUTIONS INC.

EMERGENT BIOSOLUTIONS INC. (EBS) Debt / Equity

2024-12-31: Debt/Equity Ratio 1.37.
2024-09-30: Debt/Equity Ratio 1.3.
2024-06-30: Debt/Equity Ratio 2.23.
2024-03-31: Debt/Equity Ratio 1.36.

Complete source-backed debt/equity ratio history.

Available history: 2010-12-31 to 2024-12-31
Data captured: 2026-09-04

Historical Debt/Equity Ratio

Date	Debt/Equity Ratio
2024-12-31	1.37
2024-09-30	1.3
2024-06-30	2.23
2024-03-31	1.36
2023-12-31	1.32
2023-09-30	1.24
2023-06-30	0.94
2023-03-31	1.16
2022-12-31	1.01
2022-09-30	0.74
2022-06-30	0.55
2022-03-31	0.53
2021-12-31	0.52
2021-09-30	0.56
2021-06-30	0.55
2021-03-31	0.56
2020-12-31	0.6
2020-09-30	0.7
2020-06-30	0.66
2020-03-31	0.73
2019-12-31	0.75
2019-09-30	0.8
2019-06-30	0.85
2019-03-31	0.75
2018-12-31	0.79
2017-12-31	0.01
2013-12-31	0.13
2013-09-30	0.13
2013-06-30	0.13
2013-03-31	0.14
2012-12-31	0.14
2012-09-30	0.15
2012-06-30	0.15
2011-12-31	0.14
2011-09-30	0.14
2011-06-30	0.1
2010-12-31	0.13

Annual Debt/Equity Ratio

Date	Debt/Equity Ratio
2024-12-31	1.37
2023-12-31	1.32
2022-12-31	1.01
2021-12-31	0.52
2020-12-31	0.6
2019-12-31	0.75
2018-12-31	0.79
2017-12-31	0.01
2013-12-31	0.13
2012-12-31	0.14
2011-12-31	0.14

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
ENANTA PHARMACEUTICALS INC (ENTA)	United States	$0.349B	-6.72
Larimar Therapeutics, Inc. (LRMR)	United States	$0.344B	-1.83
Vogenx, Inc. (VOGX)	United States	$0.355B
Benitec Biopharma Inc. (BNTC)	United States	$0.337B	-10.08
BioAge Labs, Inc. (BIOA)	United States	$0.333B	-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)	United States	$0.320B	-3.35
Evommune, Inc. (EVMN)	United States	$0.320B	-5.10
Prelude Therapeutics Inc (PRLD)	United States	$0.318B	-7.01
ABEONA THERAPEUTICS INC. (ABEO)	United States	$0.312B	-5.63
Rezolute, Inc. (RZLT)	United States	$0.382B	-6.45